Emerging research highlights the underexplored role of gut neuropeptides in Parkinson’s disease, revealing new connections ...

There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...

"Based on our research, there is promising potential for GLP-1RAs and SGLT2is to be considered for Alzheimer's disease prevention in the future. As use of these drugs continues to expand ...

Idiopathic REM sleep behavior ... Clinical Trial Tests Novel Stem-Cell Treatment for Parkinson's Disease Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and ...

The molecules found in Ozempic and Mounjaro could be the secret to curing Alzheimer’s and heart disease, explains ...

Orforglibron, a pill form of GLP-1 weight loss ... diabetes or heart disease, while about 4 in 10 say they took them primarily to lose weight. About 40% of adults in the U.S. have obesity ...

A new study found that patients with type 2 diabetes treated with GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors demonstrated lower risks of developing Alzheimer disease ...

The actor spoke to PEOPLE about his late father’s struggle with hallucinations and delusions after being diagnosed with Parkinson’s disease John Nacion/Variety via Getty; E. Neitzel/WireImage ...

Nearly all of the world's top pharmaceutical companies are racing to develop new oral GLP-1 drugs, including ... to "reduce the risk of kidney disease worsening, kidney failure (end-stage kidney ...

“Based on our research, there is promising potential for GLP-1RAs and SGLT2is to be considered for Alzheimer’s disease prevention in the future. As use of these drugs continues to ...